top of page

Treatment Outcomes of Bedaquiline-Resistant Tuberculosis with Dr Tasnim Hasan

Wed, 13 Aug

|

Zoom Conference

Registration is closed
See other events
Treatment Outcomes of Bedaquiline-Resistant Tuberculosis with Dr Tasnim Hasan
Treatment Outcomes of Bedaquiline-Resistant Tuberculosis with Dr Tasnim Hasan

Time & Location

13 Aug 2025, 1:00 pm – 2:00 pm AEST

Zoom Conference

Event Description

The latest instalment of the ACTnet Asia-Pacific Regional TB Journal Club was held with guest speaker Dr Tasnim Hasan, an infectious diseases and general medicine physician with extensive TB experience.


Dr Hasan has worked with Médecins Sans Frontières on both drug-sensitive and multi-drug resistant TB projects, and currently practices in remote Australian communities and Western Sydney.


The session discussed the article:


“Treatment Outcomes of Bedaquiline-Resistant Tuberculosis: A Retrospective and Matched Cohort Study”


Click here to read the article.


It was a thought-provoking discussion unpacking how rising bedaquiline resistance is impacting treatment outcomes for rifampicin-resistant TB, offering timely insights to inform future strategies and programmatic responses.


Share this event

ACTnet_edited.png

Australasian Clinical Tuberculosis Network

bottom of page